EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Synthesis of a Selective Orexin 1 Receptor Antagonist: First Scale-Up Campaign Following In-Licensing

Gary F. Breen, John S. Carey, Romain Claveau, Maciej Maczka

Organic Process Research & Development · 18.11.2026

DOI: 10.1021/acs.oprd.6c00444 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Organic Process Research & Development, online erschienen am 18.11.2026. Verfasst von Gary F. Breen und 3 weiteren Autor:innen. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Institute on Drug Abuse.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Herein, we report the synthesis of 29.2 kg of the selective orexin 1 receptor antagonist C4X3256 monohydrate via a convergent 10-stage synthetic route. (S)-2-(Methylamino)-1-[5-(trifluoromethyl)-2-pyrazinylamino]propane was synthesized in 5 stages from l-alaninamide·HCl and isolated as the crystalline HCl salt. 6-Methyl-3-(2H-1,2,3-triazol-2-yl)pyridine-2-carboxylic acid was synthesized in 4 stages from 5-bromo-2-methylpyridine and isolated as the hemidiisopropylethylamine salt. The two advanced intermediates were combined in the final stage using T3P as a coupling reagent.

Förderung

  • National Institute on Drug Abuse

Zitieren

APA

Breen, G. F., Carey, J. S., Claveau, R., & Maczka, M. (2026). Synthesis of a Selective Orexin 1 Receptor Antagonist: First Scale-Up Campaign Following In-Licensing. Organic Process Research & Development. https://doi.org/10.1021/acs.oprd.6c00444

Vancouver

Breen GF, Carey JS, Claveau R, Maczka M. Synthesis of a Selective Orexin 1 Receptor Antagonist: First Scale-Up Campaign Following In-Licensing. Organic Process Research & Development. 2026. doi:10.1021/acs.oprd.6c00444

BibTeX
@article{Breen2026,
  author = {Breen, Gary F. and Carey, John S. and Claveau, Romain and Maczka, Maciej},
  title = {Synthesis of a Selective Orexin 1 Receptor Antagonist: First Scale-Up Campaign Following In-Licensing},
  journal = {Organic Process Research & Development},
  year = {2026},
  doi = {10.1021/acs.oprd.6c00444}
}
Kostenlos starten →